Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2014
Report date:
2014

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
GLP compliance:
yes (incl. QA statement)
Test type:
acute toxic class method
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
1-[4-bromo-3-(chloromethyl)phenyl]ethan-1-one
EC Number:
942-637-5
Cas Number:
1844064-90-9
Molecular formula:
C9H8BrClO
IUPAC Name:
1-[4-bromo-3-(chloromethyl)phenyl]ethan-1-one

Test animals

Species:
rat
Strain:
Wistar
Sex:
female
Details on test animals or test system and environmental conditions:
All animals used were allowed to acclimatise to the laboratory conditions for at least 5 days.

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
cotton seed oil
Details on oral exposure:
The test item was suspended with the vehicle cottonseed oil at a concentration of 0.2 g/mL (dose of 2000 mg/kg) and of 0.03 g/ml (dose of 300 mg/kg) and administered at a dose volume of 10 mL/kg.
Doses:
2000 and 300 mg/kg body weight
No. of animals per sex per dose:
3

Results and discussion

Effect levels
Sex:
female
Dose descriptor:
LD50
Effect level:
> 300 - < 2 000 mg/kg bw
Based on:
test mat.
Mortality:
All animals of the first step treated with the test item at a dose of 2000 mg/kg died before study completion date. One animal dead spontaneously on the day of the treatment and two had to be sacrificed for ethical reasons on day 2 post-application.
Clinical signs:
other: The most relevant clinical findings in the animals treated with the test item at a dose of 2000 mg/kg bw were reduced spontaneous activity, bradykinesia, piloerection, eyes closed, kyphosis, ataxia, salivation, eyes half closed, catalepsis, moving the bed
Gross pathology:
At necropsy, no macroscopic findings were observed in any animal of both steps.
Macroscopic findings of animals not having survived until the end of the observation period: Necropsy revealed a gaseous distension of the stomach, dark discoloured duodenum and jejunum.

Applicant's summary and conclusion

Interpretation of results:
harmful
Remarks:
Migrated information Criteria used for interpretation of results: EU
Conclusions:
On the basis of the test results the substance should be classified into category 4, Harmful if ingested.
LD50 cut-off (rat): 500 mg/ kg bw